Amoéba Future Growth

Future criteria checks 0/6

Amoéba is forecast to grow earnings and revenue by 44.8% and 149% per annum respectively.

Key information

44.8%

Earnings growth rate

n/a

EPS growth rate

Chemicals earnings growth11.8%
Revenue growth rate149.0%
Future return on equityn/a
Analyst coverage

Low

Last updated22 Nov 2024

Recent future growth updates

Recent updates

Amoéba (EPA:ALMIB) Is Carrying A Fair Bit Of Debt

Oct 14
Amoéba (EPA:ALMIB) Is Carrying A Fair Bit Of Debt

Is Amoéba (EPA:ALMIB) A Risky Investment?

Apr 28
Is Amoéba (EPA:ALMIB) A Risky Investment?

Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Oct 20
Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Apr 29
Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Earnings and Revenue Growth Forecasts

ENXTPA:ALMIB - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263-4-9-51
12/31/2025N/A-6-14-71
12/31/2024N/A-6-8-61
6/30/2024N/A-13-12-7N/A
3/31/2024N/A-14-12-7N/A
12/31/2023N/A-14-13-7N/A
9/30/2023N/A-11-9-5N/A
6/30/2023N/A-7-6-4N/A
3/31/2023N/A-8-5-4N/A
12/31/2022N/A-8-5-4N/A
9/30/2022N/A-8-5-4N/A
6/30/2022N/A-8-5-5N/A
3/31/2022N/A-8-5-4N/A
12/31/2021N/A-8-4-4N/A
9/30/2021N/A-8-4-4N/A
6/30/2021N/A-8-4-4N/A
3/31/2021N/A-8-4-4N/A
12/31/2020N/A-8-3-3N/A
9/30/20200-7-3-3N/A
6/30/20200-7-3-3N/A
3/31/20200-7-3-3N/A
12/31/20190-7-4-3N/A
9/30/20190-7-4-4N/A
6/30/20190-7-4-4N/A
3/31/20190-7-5-5N/A
12/31/20180-7-6-5N/A
9/30/20180-7-6-6N/A
6/30/20180-7-6-6N/A
3/31/20180-7N/A-5N/A
12/31/20170-6N/A-5N/A
9/30/20170-6N/A-5N/A
6/30/20170-6N/A-5N/A
3/31/20170-6N/A-5N/A
12/31/20160-6N/A-6N/A
9/30/20160-6N/A-6N/A
6/30/20160-5N/A-6N/A
3/31/20160-5N/A-5N/A
12/31/20150-4N/A-4N/A
9/30/20150-3N/A-3N/A
6/30/20150-2N/A-2N/A
3/31/20150-2N/A-1N/A
12/31/20140-1N/A-1N/A
12/31/20130-1N/A1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALMIB is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ALMIB is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ALMIB is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ALMIB is forecast to have no revenue next year.

High Growth Revenue: ALMIB is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ALMIB's Return on Equity is forecast to be high in 3 years time


Discover growth companies